US Stock Movement | Performance Below Expectations, French Vaccine Company Valneva Drops Over 4% in Pre-market Trading

格隆汇 March 18｜French vaccine company Valneva fell more than 4% in US pre-market trading, currently at $10.56. According to reports, Valneva posted a Q4 2025 loss of $0.68 per share, which is 221.43% lower than the consensus estimate of $0.21. This figure represents a 25% decrease compared to the loss of $0.54 per share in the same period last year. Quarterly sales amounted to $55.516 millions, 1.20% lower than the consensus estimate of $56.19 millions. This figure is a 1.75% decrease compared to $56.504 millions in the same period last year.